# SOFIE Co. dba SOFIE – FDA Inspection, Jan 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/45f7f703-eb06-4086-8792-6fb1746b27f5
Source feed: FDA_Inspections

> FDA inspection 1195181 of SOFIE Co. dba SOFIE, January 20, 2023. Classification: Voluntary Action Indicated (VAI). 16 citations under 21 CFR part 212. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195181
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2023-01-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 16

## Related Documents

- FDA Inspection 1048176 - 2018-02-28
- FDA Inspection 931454 - 2015-06-24
- FDA Inspection 769657 - 2012-02-28
- FDA Inspection 680504 - 2010-09-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)
- [JoshRenzo N. Ramilo](https://www.keypedia.com/people/joshrenzo-n-ramilo/c88227a7-0b4b-4526-9c56-97c38ab7bcea)
- Issuing Officer

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/d7ef92ce-c94f-4719-9dcc-b0b3d3aee158

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c